AMSBIO announces MC-Easy™ minicircle technology for labs looking to produce sustained transgene expression in model animal generation and gene therapy research without the risks of introducing exogenous DNA. Minicircles are circular DNA elements that no longer contain antibiotic resistance markers or the bacterial origin of replication. These small vectors can be used in vivo or […]
New targeted sequencing workflow combines pre-validated content with easy customization and new analysis tools to accelerate variant discovery and screening (ANN ARBOR, Mich.) Swift Biosciences today announced the commercial release of its Accel-Amplicon Plus™ Cancer NGS Panels, a suite of nine tumor-specific and focused gene panels to facilitate targeted cancer sequencing. The Accel-Amplicon technology enables simultaneous detection […]
SAN FRANCISCO, Calif. – Twist Bioscience Corporation, a company enabling customers to succeed through its offering of high-quality synthetic DNA, today announced that the company has expanded its presence in Asia Pacific, adding strategic distribution partners for synthetic DNA (genes, gene fragment, oligo pool product lines) as well as the exome and custom target enrichment product […]
RESEARCH TRIANGLE PARK, N.C. — RTI International, a leading research institute, today announced a strategic collaboration with PierianDx, to help solve the problem of translating complex genomic data into actionable clinical insights to advance precision medicine. The collaboration includes investment and other strategic support to help advance PierianDx’s growth plan. “Next-generation sequencing is a rapidly evolving scientific field […]
World’s first commercially available platform for high-throughput single-cell DNA analysis expands capabilities to include HiSeq and new targeted panels CHICAGO.—Mission Bio, Inc., a leader in single-cell DNA analysis and precision genomics, today announced at the American Association for Cancer Research 2018 annual meeting multiple premier cancer centers have added the Tapestri platform to their laboratories. […]
CHICAGO — One in 285 children born in the U.S. this year alone will be diagnosed with cancer before their 20th birthday1, yet, until recently, too little was known about the genetic alterations that drive their cancers to appropriately manage the disease. To address this global issue, Thermo Fisher Scientific today announces it has established the International […]
Comprehensive circulating tumor DNA reference materialS FOR NGS assay development, validation, and daily run controls MILFORD, Mass. — SeraCare Life Sciences, a manufacturer and leading partner to global in vitro diagnostics manufacturers and clinical laboratories, announces two new upcoming additions to the Seraseq™ Circulating Tumor DNA (ctDNA) portfolio of reference materials, ctDNA Complete™ and ctDNA Panels. These new reference […]
Mr. Lubniewski assumes the role after having served for seven years as Chief Business Officer TUCSON, Ariz. — HTG Molecular Diagnostics, Inc. (Nasdaq:HTGM), a provider of instruments, reagents, and services for molecular profiling applications, today announced the promotion of John Lubniewski to President and Chief Operating Officer. Mr. Lubniewski has served as HTG’s chief business officer for the past […]
After the announcement of investing in 10 PacBio Sequel Systems in earlier 2018,Annoroad plans to increase its collaboration with Pacific Biosciences. The two parties plan to collaborate, based on PacBio’s SMRT® Sequencing technology, in the areas of plant & animal genome studies, basic research in human biomedical sciences and translational medicine. In 2017, Annoroad declared its […]
The Genoox Integrated Platform is Designed to Offer Solutions for Combining Genoox Technology for Aligning and Calling NGS Short-Reads with Bionano Genome Mapping Technology to Better Understand Complexities of DNA Mutations SAN FRANCISCO–Genoox, the healthcare technology company on a mission to make it easier for doctors, clinicians and researchers to run clinical genetic applications and […]
Pay Invoice
Latest Blogs
-
MOBILion Expands into Proteomics MS Market
April 30, 2026 5:05 pm
-
Carterra Introduces Faster SPR
March 27, 2026 7:26 pm
-
New Report Details Higher Education Science R&D Spending
February 27, 2026 3:23 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
